tak-475 and farnesyl-pyrophosphate

tak-475 has been researched along with farnesyl-pyrophosphate* in 1 studies

Other Studies

1 other study(ies) available for tak-475 and farnesyl-pyrophosphate

Article	Year
Synthesis of novel 4,1-benzoxazepine derivatives as squalene synthase inhibitors and their inhibition of cholesterol synthesis. Journal of medicinal chemistry, 2002, Sep-26, Volume: 45, Issue:20 Modification of the carboxyl group at the 3-position and introduction of protective groups to the hydroxy group of the 4,1-benzoxazepine derivative 2 (metabolite of 1) were carried out, and the inhibitory activity for squalene synthase and cholesterol synthesis in the liver was investigated. Among these compounds, the glycine derivative 3a and beta-alanine derivative 3f exhibited the most potent inhibition of squalene synthase prepared from HepG2 cells (IC(50) = 15 nM). On the other hand, the piperidine-4-acetic acid derivative 4a, which was prepared by acetylation of 3j, was the most effective inhibitor of cholesterol synthesis in rat liver (ED(50) = 2.9 mg/kg, po). After oral administration, 4a was absorbed and rapidly hydrolyzed to deacylated 3j. Compound 3j was detected mainly in the liver, but the plasma level of 3j was found to be low. Compounds 3j and 4a were found to be competitive inhibitors with respect to farnesyl pyrophosphate. Further evaluation of 4a as a cholesterol-lowering and antiatherosclerotic agent is underway. Topics: Animals; Anticholesteremic Agents; Azepines; Cholesterol; Enzyme Inhibitors; Farnesyl-Diphosphate Farnesyltransferase; Humans; Liver; Male; Oxazepines; Piperidines; Polyisoprenyl Phosphates; Rats; Rats, Wistar; Sesquiterpenes; Structure-Activity Relationship	2002

Article

Year

Synthesis of novel 4,1-benzoxazepine derivatives as squalene synthase inhibitors and their inhibition of cholesterol synthesis.

Journal of medicinal chemistry, 2002, Sep-26, Volume: 45, Issue:20

Modification of the carboxyl group at the 3-position and introduction of protective groups to the hydroxy group of the 4,1-benzoxazepine derivative 2 (metabolite of 1) were carried out, and the inhibitory activity for squalene synthase and cholesterol synthesis in the liver was investigated. Among these compounds, the glycine derivative 3a and beta-alanine derivative 3f exhibited the most potent inhibition of squalene synthase prepared from HepG2 cells (IC(50) = 15 nM). On the other hand, the piperidine-4-acetic acid derivative 4a, which was prepared by acetylation of 3j, was the most effective inhibitor of cholesterol synthesis in rat liver (ED(50) = 2.9 mg/kg, po). After oral administration, 4a was absorbed and rapidly hydrolyzed to deacylated 3j. Compound 3j was detected mainly in the liver, but the plasma level of 3j was found to be low. Compounds 3j and 4a were found to be competitive inhibitors with respect to farnesyl pyrophosphate. Further evaluation of 4a as a cholesterol-lowering and antiatherosclerotic agent is underway.

Topics: Animals; Anticholesteremic Agents; Azepines; Cholesterol; Enzyme Inhibitors; Farnesyl-Diphosphate Farnesyltransferase; Humans; Liver; Male; Oxazepines; Piperidines; Polyisoprenyl Phosphates; Rats; Rats, Wistar; Sesquiterpenes; Structure-Activity Relationship

2002